Cat Number Product name Supplier Quantity Price Tech More
BR01015 Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011 US Biomax 278.00 € Publication
OS803 Chondrosarcoma tissue tissue array, 27 cases 80 cores, replacing BS36011 US Biomax 266.00 € Publication
LC813 Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014 US Biomax 231.00 € Publication
FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
T173a Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR728 Breast carcinoma tissue array, with stage and grade info, 24 cases 72 cores, replacing BC08015 US Biomax 231.00 € Publication
PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185.00 € Publication
MC246 Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
FMC409 Multiple organ cancer frozen tissue array, 20 cases 40 cores replacing FMC401 US Biomax 281.00 € Publication
BS17016a Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed US Biomax 267.00 € Publication
RAT901 Rat multiple organs, normal tissue array, 22 cases 90 cores, replacing BR01013 US Biomax 231.00 € Publication
BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed US Biomax 258.00 € Publication
ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429.00 € Publication
HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 US Biomax 266.00 € Publication
CR244 Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241 US Biomax 189.00 € Publication
T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
ES1202 Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201 US Biomax 278.00 € Publication
T054a Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR1503 Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 US Biomax 278.00 € Publication
OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed US Biomax 105.00 € Publication
LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011 US Biomax 231.00 € Publication
FDA808a-1 Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed US Biomax 267.00 € Publication
T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105.00 € Publication
BR803 Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016 US Biomax 189.00 € Publication
PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210.00 € Publication
BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185.00 € Publication
MC542 Multiple organ diseased tissue array, including TNM and pathology grade, 54 cases 54 cores, replacing MC541 US Biomax 160.00 € Publication
GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed US Biomax 487.00 € Publication
CO243a Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed US Biomax 105.00 € Publication
SK801b Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801 US Biomax 321.00 € Publication
BN01011b Normal stomach tissue array, 24 cases 72 cores, replacing BN01011 US Biomax 277.00 € Publication
ME804 Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 US Biomax 266.00 € Publication
LC10013 Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002 US Biomax 266.00 € Publication
LC725 Normal lung tissue array, 24 cases 72 cores, replacing BN04011 US Biomax 278.00 € Publication
FBN406 Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404 US Biomax 167.00 € Publication
T088 Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085 US Biomax 88.00 € Publication
BR243b Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
PA241b Pancreas adenocarcinoma tissue array with matched adjacent normal pancreas tissue, including TNM and pathology grade, 6 cases 24 cores, replacing PA241 US Biomax 99.00 € Publication
LV809 Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases 80 cores, replacing BS03014 US Biomax 231.00 € Publication
FDA999a Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc US Biomax 429.00 € Publication
PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185.00 € Publication
MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed US Biomax 320.00 € Publication
GL806a Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed US Biomax 258.00 € Publication
CO725 Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05041 US Biomax 231.00 € Publication
ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210.00 € Publication
BN129 Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116 US Biomax 160.00 € Publication
NHL482 Lymphoma tissue array, 48 cases 48 cores, replacing NHL481 US Biomax 189.00 € Publication
BO244 Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replacing BO243 US Biomax 100.00 € Publication
OS802 Osteosarcoma and chondrosarcoma tissue array, with stage, grade and TNM data, 80 cases 80 cores, replacing BC26111 US Biomax 266.00 € Publication
LC808 Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases 80 cores, replacing BS04011 US Biomax 231.00 € Publication
FDA806 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 380.00 € Publication
T142a Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR727 Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011 US Biomax 231.00 € Publication
PA805 Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802 US Biomax 266.00 € Publication
MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88.00 € Publication
FMC407b Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed US Biomax 626.00 € Publication
TH809a Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed US Biomax 258.00 € Publication
PR956 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir US Biomax 487.00 € Publication
BCN963 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 US Biomax 266.00 € Publication
ME1004a Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
CO952 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi US Biomax 429.00 € Publication
ST808 Stomach adenocarcinoma and normal tissue array, 80 cases 80 cores, replacing BS01032 US Biomax 231.00 € Publication
EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
T054 Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052 US Biomax 88.00 € Publication
BR1008 Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212 US Biomax 266.00 € Publication
OV20814 Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases 208 cores, replacing OV2084 US Biomax 558.00 € Publication
LV723 Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013 US Biomax 231.00 € Publication
FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
T195 Prostate adenocarcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, 2 serial sections, replacing T192 US Biomax 113.00 € Publication
BR802b Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases 80cores, replacing BR802 US Biomax 266.00 € Publication
PR243a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed US Biomax 105.00 € Publication
BC07013 Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011 US Biomax 160.00 € Publication
MC5003 High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002 US Biomax 634.00 € Publication
FRA901a-2 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c US Biomax 626.00 € Publication
CO242a Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed US Biomax 81.00 € Publication
SK244 Age grouped female skin tissue array, 12 cases 24 cores, replacing SK243 US Biomax 99.00 € Publication
BN00119 Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112 US Biomax 266.00 € Publication
ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
LC10012 Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 US Biomax 266.00 € Publication
LC724 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04031 US Biomax 231.00 € Publication
ES8010 Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases 80 cores, replacing ES801 US Biomax 231.00 € Publication
T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR243a Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243 US Biomax 99.00 € Publication
PA2072 Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207 US Biomax 456.00 € Publication
LV805 Liver cirrhosis and hepatitis tissue array, 80 cases 80 cores, replacing IC03001 US Biomax 231.00 € Publication
FDA999 Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA998 US Biomax 314.00 € Publication
T291a Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin US Biomax 114.00 € Publication
BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 US Biomax 456.00 € Publication
PR803 Prostate cancer tissue array with unmatched normal prostate tissue, 80 cases 80 cores, replacing PR801 US Biomax 231.00 € Publication
BC110118 Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012 US Biomax 231.00 € Publication
MC802 Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases 80 cores, with grade information US Biomax 266.00 € Publication
GL806 Brain glioblastoma and normal tissue array, 40 cases 80 cores, replacing GL805 US Biomax 266.00 € Publication
CO724 Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05031 US Biomax 278.00 € Publication
ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185.00 € Publication
BN126 Multiple organ normal tissue array, replacing BN113, 45 cases 45 cores US Biomax 231.00 € Publication
NHL401a Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
BN961 Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861 US Biomax 266.00 € Publication
OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed US Biomax 258.00 € Publication
LC807 Lung cancer and normal tissue array, with TNM and grade info, 77 cases 80 cores, replacing BC04014 US Biomax 231.00 € Publication
FDA805 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 314.00 € Publication
T141a Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR246a Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246 US Biomax 99.00 € Publication
PA802 Multiple pancreatic cancer tissue array with unmatched normal tissues, with TNM data, 78 cases 80 cores, replacing PA801, to be replaced by PA805 US Biomax 266.00 € Publication
MC244 Multiple organ cancer and normal adjacent tissue array, replacing MC241, 12 cases 24 cores US Biomax 88.00 € Publication
FMC405a Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed US Biomax 626.00 € Publication
TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267.00 € Publication
BRN801 Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013 US Biomax 231.00 € Publication
PR955 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR954 US Biomax 558.00 € Publication
BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores US Biomax 231.00 € Publication
ME1004 Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM, 100 cases 100 cores, replacing ME1003 US Biomax 314.00 € Publication
HN483 Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482 US Biomax 160.00 € Publication
CO806 Colon normal adjacent tissue array, replacing BN05012, 80 cases 80 cores US Biomax 231.00 € Publication
ST807 Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 cores US Biomax 231.00 € Publication
T045c Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267.00 € Publication
LN802 Multiple organ lymph tissue array, 80 cases 80 cores, replacing LN801 US Biomax 231.00 € Publication
FDA808-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 US Biomax 277.00 € Publication
T175 Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed US Biomax 105.00 € Publication
BR8018 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014 US Biomax 266.00 € Publication
PR243 Prostate cancer and normal tissue array, with stage and grade info, 12 cases 24 cores, replacing PR241 US Biomax 88.00 € Publication
BC05118a Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
MC5002 High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001 US Biomax 634.00 € Publication
FRA901a-1 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c US Biomax 626.00 € Publication
CO241a Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed US Biomax 105.00 € Publication
RE724 Rectal adenocarcinoma (grade 3) tissue array, with stage, TNM and grade info, 24 cases 72 cores, replacing BS06041 US Biomax 231.00 € Publication
BM483 Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482 US Biomax 266.00 € Publication
ME802 Malignant melanoma with normal skin tissue array, 40 cases 80 cores, replacing BS38011 US Biomax 266.00 € Publication
LC10010a Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
CyFDA1 FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
ES781 Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111 US Biomax 266.00 € Publication
T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456.00 € Publication
OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258.00 € Publication
LV804 Liver cancer tissue array with normal tissue from autopsy, 38 cases 80 cores, replacing BS03011 US Biomax 231.00 € Publication
FDA994 FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995 US Biomax 314.00 € Publication
T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267.00 € Publication
PR8011 Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805 US Biomax 314.00 € Publication
BC081120 Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115 US Biomax 266.00 € Publication
MC801 Multiple cancer tissue array, replacing BC00012, 80 cases 80 cores, with grade information US Biomax 266.00 € Publication
GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
CO723 Colon well differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05021 US Biomax 231.00 € Publication
ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed US Biomax 487.00 € Publication
BN1002a Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
MS481a Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
LC723 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04071 US Biomax 231.00 € Publication
LC806 Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013 US Biomax 231.00 € Publication
FDA800 Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2 US Biomax 266.00 € Publication
T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
PA721 Pancreatic carcinoma (multi tissue combined panel), 24 cases 72 cores, replacing BC14012 US Biomax 231.00 € Publication
LY121a Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed US Biomax 185.00 € Publication
FMC402b Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed US Biomax 626.00 € Publication
TE242 Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing TE241 US Biomax 88.00 € Publication
BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
PR809 Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases 80 cores, replacing BC19019 US Biomax 266.00 € Publication
BC21014 Skin malignant tumor tissue array, 78 cases 78 cores, replacing BC21011 US Biomax 231.00 € Publication
MCN602 Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 US Biomax 231.00 € Publication
HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
CO804 Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores US Biomax 231.00 € Publication
ST801a Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed US Biomax 267.00 € Publication
BN501 Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013 US Biomax 160.00 € Publication
NHL803b Lymphoma tissue array, 80 cases 80 cores, replacing NHL803 US Biomax 321.00 € Publication
BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme US Biomax 296.00 € Publication
OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266.00 € Publication
LM801a Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed US Biomax 267.00 € Publication
FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
T174a Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 US Biomax 231.00 € Publication
PR242a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed US Biomax 105.00 € Publication
BC04119b Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119 US Biomax 336.00 € Publication
MC484 Multiple organs tumor and normal adjacent tissue, replacing BC00113, 44 cases 48 cores US Biomax 160.00 € Publication
FRA901a Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed US Biomax 858.00 € Publication
CO1002b Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002 US Biomax 321.00 € Publication
RE723 Rectal adenocarcinoma (grade 2) tissue array, with stage, TNM and grade, 24 cases 72 cores, replacing BS06031 US Biomax 231.00 € Publication
BL806 Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801 US Biomax 266.00 € Publication
ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185.00 € Publication
KD803 Normal kidney tissue array, replacing BN07012, 80 cases 80 cores US Biomax 231.00 € Publication
CR803 Multiple (uterine cervix) cervical squamous cancer tissue array, 80 cases 80 cores, replacing BS10011 US Biomax 231.00 € Publication
T045b Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 US Biomax 99.00 € Publication
ES723 Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031 US Biomax 231.00 € Publication
T086 Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084 US Biomax 88.00 € Publication
BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a US Biomax 456.00 € Publication
OV802 Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011 US Biomax 231.00 € Publication
LV803 Liver carcinoma (combination of cancer, cancer adjacent and normal tissue), 53 cases 72 cores, replacing BC03021 US Biomax 231.00 € Publication
FDA902b FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing US Biomax 1 206.00 € Publication
T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR804 Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores US Biomax 231.00 € Publication
PR8010 Prostate cancer tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR802 US Biomax 266.00 € Publication
BC08022 Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases 63 cores, replacing BN08021 US Biomax 160.00 € Publication
MC641 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115 US Biomax 0.00 € Publication
GL803 Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases 80 cores, replacing BS17015 US Biomax 266.00 € Publication
CO722 Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases 72 cores, replacing BC05021 US Biomax 231.00 € Publication
ST1004 Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed US Biomax 258.00 € Publication
BN1002 Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001 US Biomax 266.00 € Publication
MO1601 Mouse tissue array of liver, kidney, lung, muscle, brain, heart, stomach, spleen, 160 cases 160 cores, replacing BM01011 US Biomax 278.00 € Publication
LC721 Non small cell lung carcinoma (NSCLC) tissue array, 24 cases 72 cores, replacing BC04011 US Biomax 231.00 € Publication
LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228.00 € Publication
FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 US Biomax 781.00 € Publication
T113a Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
PA483a Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed US Biomax 185.00 € Publication
LY1001a Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
FMC282a Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed US Biomax 394.00 € Publication
T392 Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T391 US Biomax 88.00 € Publication
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 US Biomax 314.00 € Publication
PR808 Prostate cancer and normal tissue array, with TNM, stage, Gleason's score and grade info, 40 cases 80 cores, replacing BC19012 US Biomax 266.00 € Publication
BC19019 Prostate cancer and hyperplasia tissue array, 33 cases 63 cores, replacing BC19011 US Biomax 231.00 € Publication
MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 US Biomax 266.00 € Publication
HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed US Biomax 258.00 € Publication
ST723 Stomach poorly differentiated adenocarcinoma tissue array with adjacent normal control, stage and grade info, 24 cases 72 cores, replacing BS01042 US Biomax 231.00 € Publication
BN243a Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed US Biomax 105.00 € Publication
NHL803 Lymphoma tissue array, 80 cases 80 cores, replacing LM802 US Biomax 266.00 € Publication
BR10010 Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004 US Biomax 314.00 € Publication
OS804 Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011 US Biomax 266.00 € Publication
LM482a Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed US Biomax 320.00 € Publication
FDA807-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 US Biomax 336.00 € Publication
T174 Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171 US Biomax 88.00 € Publication
BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231.00 € Publication
PA961a Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed US Biomax 258.00 € Publication
BC041115a Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
MC483 Multiple types of cancer tissue array with normal control, replacing BC00119, 26 cases 48 cores, with stage and grade data US Biomax 160.00 € Publication
FMC409a Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed US Biomax 626.00 € Publication
CMA241a Human tumor cell array, 12 cell lines 24 cores, replacing CMA241; ihc Anti-Actin confirmed US Biomax 267.00 € Publication
RE722 Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022 US Biomax 231.00 € Publication
BL802 Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012 US Biomax 266.00 € Publication
ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed US Biomax 105.00 € Publication
IC00011b Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011 US Biomax 321.00 € Publication
CR602 Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601 US Biomax 231.00 € Publication
T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
ES722 Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023 US Biomax 231.00 € Publication
T084 Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases 24 cores, replacing T082 US Biomax 88.00 € Publication
BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- US Biomax 296.00 € Publication
OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228.00 € Publication
LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
FDA808a-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed US Biomax 267.00 € Publication
T203a Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258.00 € Publication
PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296.00 € Publication
BC07015 Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012 US Biomax 231.00 € Publication
MC631 Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014 US Biomax 160.00 € Publication
GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed US Biomax 210.00 € Publication
SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed US Biomax 267.00 € Publication
BN05014 Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011 US Biomax 160.00 € Publication
MO1002 Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replacing MO32011 US Biomax 189.00 € Publication
LC1006 Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001 US Biomax 231.00 € Publication
LC726 Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016 US Biomax 231.00 € Publication
FBN407 Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404 US Biomax 281.00 € Publication
T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed US Biomax 90.00 € Publication
PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105.00 € Publication
LVN801 Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 US Biomax 231.00 € Publication
FFE302 Multiple organ normal frozen tissue array, 15 cases 30 cores, replacing FFE301 US Biomax 199.00 € Publication
T386 Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T385 US Biomax 88.00 € Publication
BR962 Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701 US Biomax 231.00 € Publication
PR807a Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed US Biomax 296.00 € Publication
BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162.00 € Publication
MC809a Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed US Biomax 382.00 € Publication
GL811 Brain tumor and normal tissue array, with pathology grade, 27 cases 81 cores, replacing BS17011 US Biomax 266.00 € Publication
CO726 Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112 US Biomax 266.00 € Publication
ST721 Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data, 24 cases 72 cores, replacing BC01011 US Biomax 231.00 € Publication
BN243 Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241 US Biomax 88.00 € Publication
NHL802a Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed US Biomax 267.00 € Publication
Cat Number Product name Supplier Quantity Price Tech More